Professor Krishnan Bhaskaran
of Statistical Epidemiology and Wellcome Senior Research Fellow
I graduated from Sheffield University with a BSc Hons in Mathematics in 1999 and took an MSc in Medical Statistics at Leicester University in 2000-2001. I worked for 6 years at the MRC Clinical Trials Unit, on a variety of HIV trials and observational studies, with an emphasis on HIV seroconverters (individuals with well estimated dates of HIV infection). In October 2010, on gaining my PhD at LSHTM for a project looking at environmental risk factors for heart disease, I joined the department as a lecturer, and later senior lecturer. I completed an National Institute for Health Research postdoctoral fellowship to study the effects of widely prescribed drugs on cancer risk (2012-2014). I was then awarded a Wellcome Trust/Royal Society Sir Henry Dale Fellowship followed by a Wellcome Senior Research Fellowship to study cardiovascular disease risks among people with a history of cancer (2015 to present).
I am joint Research Degrees Co-ordinator for the Department of Non-Communicable Diseases Epidemiology, and co-director of the Extended Epidemiology MSc module. I deliver several lectures and practical sessions on the MSc in Epidemiology. I teach on the Extended Epidemiology, and Advanced Statistical Methods for Epidemiology (ASME) MSc modules, and on the Advanced Course in Epidemiological Analysis (ACEA) and Practical Pharmacoepidemiology short courses.
My main research focus is on cancer epidemiology and cancer survivorship, and I lead the Beyond Cancer research group (https://www.lshtm.ac.uk/research/centres-projects-groups/beyond-cancer), funded by my Wellcome Senior Research Fellowship. Our aims are to investigate the long-term health consequences of cancer and its treatment, including vascular health, mental health, and other outcomes.
I am one of the statistical leads on OpenSAFELY, a data platform and research collaboration set up at the start of the 2019 COVID-19 pandemic, and designed to use linked health data sources covering most of the population of England to answer key questions about this emerging disease.
I am also interested in pharmacoepidemiology, health effects of obesity, and methodological issues in the analysis of electronic health records.